Subscribe To
AEZS / Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year?
AEZS News
By Zacks Investment Research
March 23, 2023
Aeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimates
Aeterna Zentaris (AEZS) delivered earnings and revenue surprises of 9.68% and 134.43%, respectively, for the quarter ended December 2022. Do the numbe more_horizontal
By Zacks Investment Research
February 7, 2023
Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year?
Here is how Aeterna Zentaris (AEZS) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year. more_horizontal
By GlobeNewsWire
February 7, 2022
Aeterna Zentaris to Present at the 2022 BIO CEO & Investor Conference
CHARLESTON, S.C., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty more_horizontal
By GlobeNewsWire
February 7, 2022
Aeterna Zentaris to Present at the 2022 BIO CEO & Investor Conference
CHARLESTON, S.C., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty more_horizontal
By GlobeNewsWire
February 7, 2022
Aeterna Zentaris to Present at the 2022 BIO CEO & Investor Conference
CHARLESTON, S.C., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty more_horizontal